TradingKey

• Tesla reported strong earnings, rising free cash flow, and improved automotive gross margins. • High-margin software growth, energy storage deployments, and potential SpaceX synergies boosted sentiment. • TSLA shows a buy MACD signal and an overbought Williams %R reading.

• AMD gained momentum from bullish analyst upgrades and anticipated third-quarter earnings. • Hyperscaler artificial intelligence infrastructure expansion and server processor demand drove optimism. • Technical indicators showed mixed signals while annual revenue reached $34.64B.

• Intel shares rose on analyst upgrades and artificial intelligence demand optimism. • The company acquired quantum computing software developer Classiq to advance computing architectures. • Intel reports third-quarter earnings on October 29 amid strong institutional interest.

• Oracle shares rose amid volatility ahead of its Investor Day meeting. • Growth in cloud infrastructure demand boosted market confidence and institutional buying. • Analysts maintain constructive outlook despite heavy capital expenditures and mixed technical indicators.

• Broadcom gained momentum from custom AI silicon developments and Anthropic infrastructure financing. • Wall Street analysts upgraded Broadcom with higher price targets and positive sentiment. • Technical indicators show neutral conditions while market sentiment remains in the bullish zone.

• USD/MXN momentum rose from U.S. dollar demand and interest-rate differential pressures. • A narrowing U.S.-Mexico interest-rate spread eroded the Mexican peso's yield advantage. • Technical indicators show a neutral MACD, neutral RSI, and buy Williams %R.

Ripple and Robinhood announced a strategic partnership integrating Ripple’s stablecoin, institutional markets and treasury infrastructure into Robinhood’s ecosystem and financial operations.

TradingKey - Microsoft (MSFT) will report its first-quarter fiscal 2027 earnings after the market close on October 28, Eastern Time. As its stock price reclaims $530 and approaches record highs, this earnings report could determine whether Microsoft can sustain the rally driven by demand for Azure and artificial intelligence.

TradingKey - As of press time in US pre-market trading on October 27 ET, Broadcom (AVGO) shares rose about 3.32% to $340.10.

Esquire Financial Holdings (NASDAQ: ESQ) reported Q3 2026 total revenue of $61.4 million, up 63.4% year over year, as two months of Signature results lifted net interest income 70.6% to $53.5 million. GAAP net income rose 24.4% to $17.5 million, but diluted EPS slipped to $1.57 from $1.62 as the share count expanded. Merger costs and core deposit intangible amortization pushed the reported efficiency ratio to 58.6%, while adjusted diluted EPS reached $2.12 and the adjusted efficiency ratio improved to 41.1%.

TradingKey - Boeing stock forecast: BA holds $183.84 support under a falling trendline ahead of Q3 results, where free cash flow matters more than earnings per share.

Camden National (NASDAQ: CAC) reported Q3 2026 net income of $22.8 million and diluted EPS of $1.34, up 8% and 7% year over year. Net interest income rose 8% to $55.4 million as 5% sequential deposit growth reduced reliance on borrowings and lifted net interest margin to 3.41%. Total loans remained near $5.0 billion, while non-interest income fell 6% year over year. Credit quality remained stable, although higher securities unrealized losses reduced tangible book value and the tangible common equity ratio from the prior quarter.

TradingKey - Intel (INTC) will release its third-quarter 2026 financial results after the market close on October 29 Eastern Time, as its stock price pulls back to near a three-month low.

Ecolab’s Q3 2026 revenue rose 13% to $4.69 billion as organic sales increased 7%, supported by 5% pricing and 2% volume growth. Adjusted operating income climbed 14% to $893.4 million, while adjusted diluted EPS advanced 5% to $2.18. Reported EPS fell 5% to $1.95 as acquisition-related amortization, financing, and integration costs weighed on results. Global Water and Life Sciences led segment growth, and Ecolab set full-year adjusted EPS guidance at $8.10 to $8.20, with Q4 organic sales expected to rise 6% to 7%.

TradingKey - In pre-market trading on October 27, Eastern Time, futures tied to the three major US stock indices rose across the board. As of press time, Dow futures were up slightly by 0.21%, S&P 500 futures gained 0.23%, and Nasdaq 100 futures advanced by approximately 0.34%.

Boeing’s Q3 2026 revenue rose 4% to $24.19 billion, while its GAAP diluted loss narrowed to $0.26 per share from $7.14 a year earlier. The company returned to a $354 million operating profit and generated $1.50 billion of operating cash flow, with free cash flow reaching $464 million. Defense and Global Services growth offset a 3% decline in Commercial Airplanes revenue, which remained loss-making. Investors should watch commercial production costs, heavy interest expense, defense margin quality, and whether positive quarterly cash flow can overcome negative year-to-date free cash flow.

TradingKey - Celestica stock forecast: CLS jumps premarket after a $40 billion 2027 outlook, putting C$379.86 resistance in play after an oversold slide on the 4-hour chart.

TradingKey - Amazon (AMZN) will release its third-quarter 2026 financial results after the U.S. market close on October 29, Eastern Time, and hold an earnings conference call at 17:00 on the same day.

SunCoke Energy’s Q3 2026 revenue was $485.9 million, down 0.2% year over year, while diluted EPS eased to $0.25 from $0.26. Adjusted EBITDA increased 30.1% to $76.9 million as Industrial Services benefited from an additional month of Phoenix results and higher terminal volumes, while Domestic Coke gained from sales mix and favorable coal-to-coke yields despite lower volume. Operating income rose to $40.6 million, but the loss of prior-year tax credits kept net income flat. The company now expects full-year adjusted EBITDA to modestly exceed $265 million.

HCA Healthcare’s Q3 2026 revenue rose 3.6% to $19.849 billion, while diluted EPS increased 4.5% to $7.27. Net income attributable to HCA fell 3.9% to $1.579 billion as a shift toward uninsured patients created an estimated $400 million unfavorable pre-tax impact. Same-facility equivalent admissions grew 3.0%, but same-facility inpatient and outpatient surgeries declined. Operating cash flow edged up to $4.461 billion, and the company said full-year operating results should land in the upper half of its previously issued 2026 guidance ranges.